Status:
WITHDRAWN
Azithromycin in Control of Trachoma II
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Trachoma
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Trachoma is the world's leading cause of preventable blindness. This disease, caused by Chlamydia trachomatis, is endemic in many parts of the developing world. In 1990s we evaluated the use of commun...
Detailed Description
This is operational research aimed at better defining the use of oral azithromycin as part of the SAFE strategy to eliminate blinding trachoma. 1. Before the examinations, we will do a census and a s...
Eligibility Criteria
Inclusion
- Person resides within a selected rural village in a trachoma-endemic area of Egypt.
Exclusion
- Person does not reside in one of the three rural villages being studied.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00286026
Start Date
June 1 2005
End Date
August 1 2009
Last Update
April 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143